Genetic variations in DNA could help improve efficacy of clinical trials

The evolution of medicine relies heavily on the results of clinical trials, which while essential, are extremely costly and carry the potential of unintended adverse consequences. Now researchers from the University of Bristol have devised a new DNA-based method that could better predict whether clinical trials will be effective, potentially saving millions of pounds and ultimately improving the lives of patients.
Source: University of Bristol news - Category: Universities & Medical Training Tags: Research; Faculty of Health Sciences, Bristol Medical School, Faculty of Health Sciences, Faculty of Health Sciences, Population Health Sciences; Press Release Source Type: news